カペシタビンの世界市場レポート2020

• 英文タイトル：Global Capecitabine Sales Market Report 2020

• レポートコード：20QY06-01401 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥600,000 (USD4,000)	▷ お問い合わせ
Multi User	￥900,000 (USD6,000)	▷ お問い合わせ
Enterprise License	￥1,200,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社の当調査資料では、カペシタビンのグローバル市場について種類別（500mg、150mg）、用途別（乳癌、大腸癌、胃癌）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・カペシタビン市場の概要 ・世界の主要地域別カペシタビン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のカペシタビン市場規模2015-2026：種類別（500mg、150mg） ・世界のカペシタビン市場規模2015-2026：用途別（乳癌、大腸癌、胃癌） ・カペシタビンの北米市場規模2015-2020 ・カペシタビンのヨーロッパ市場規模2015-2020 ・カペシタビンの中国市場規模2015-2020 ・カペシタビンの日本市場規模2015-2020 ・カペシタビンの東南アジア市場規模2015-2020 ・カペシタビンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Roche、、Teva、、Mylan、、Hikma、、Hengrui Medicine、、Cipla、、Reliance Group、、Hetero、） ・カペシタビンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・カペシタビンの市場動向・機会・課題 ・調査の結論

Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.

Capecitabine is a prescription medication used to treat breast cancer and cancer of the colon or rectum. Capecitabine belongs to a group of drugs called antimetabolites which work by interfering with DNA production, stopping cells from multiplying. The medication comes in tablet form and is usually taken twice daily, within 30 minutes after the end of a meal. The proportion of breast cancer with Handle in 2016 is about 40%, and the proportion of colorectal cancer in 2016 is about 31.94%.

Market Analysis and Insights: Global Capecitabine Market

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Capecitabine market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Capecitabine industry.

Based on our recent survey, we have several different scenarios about the Capecitabine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 1043 million in 2019. The market size of Capecitabine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

Global Capecitabine Scope and Market Size

The global Capecitabine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Capecitabine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Capecitabine market is segmented into

500 mg

150 mg

Segment by Application, the Capecitabine market is segmented into

Breast Cancer

Colorectal Cancer

Stomach Cancer

The Capecitabine market is analysed and market size information is provided by regions (countries). Segment by Application, the Capecitabine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.

The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Capecitabine Market Share Analysis

Capecitabine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Capecitabine business, the date to enter into the Capecitabine market, Capecitabine product introduction, recent developments, etc.

The major vendors covered:

Roche

Teva

Mylan

Hikma

Hengrui Medicine

Cipla

Reliance Group

Hetero

レポート目次

---

1 Capecitabine Market Overview

1.1 Capecitabine Product Scope

1.2 Capecitabine Segment by Type

1.2.1 Global Capecitabine Sales by Type (2020-2026)

1.2.2 500 mg

1.2.3 150 mg

1.3 Capecitabine Segment by Application

1.3.1 Global Capecitabine Sales Comparison by Application (2020-2026)

1.3.2 Breast Cancer

1.3.3 Colorectal Cancer

1.3.4 Stomach Cancer

1.4 Capecitabine Market Estimates and Forecasts (2015-2026)

1.4.1 Global Capecitabine Sales Growth Rate (2015-2026)

1.4.2 Global Capecitabine Revenue and Growth Rate (2015-2026)

1.4.3 Global Capecitabine Price Trends (2015-2026)

1.5 Coronavirus Disease 2019 (Covid-19): Capecitabine Industry Impact

1.5.1 How the Covid-19 is Affecting the Capecitabine Industry

1.5.1.1 Capecitabine Business Impact Assessment – Covid-19

1.5.1.2 Supply Chain Challenges

1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products

1.5.2 Market Trends and Capecitabine Potential Opportunities in the COVID-19 Landscape

1.5.3 Measures / Proposal against Covid-19

1.5.3.1 Government Measures to Combat Covid-19 Impact

1.5.3.2 Proposal for Capecitabine Players to Combat Covid-19 Impact

2 Capecitabine Estimate and Forecast by Region

2.1 Global Capecitabine Market Size by Region: 2015 VS 2020 VS 2026

2.2 Global Capecitabine Retrospective Market Scenario by Region (2015-2020)

2.2.1 Global Capecitabine Sales Market Share by Region (2015-2020)

2.2.2 Global Capecitabine Revenue Market Share by Region (2015-2020)

2.3 Global Capecitabine Market Estimates and Forecasts by Region (2021-2026)

2.3.1 Global Capecitabine Sales Estimates and Forecasts by Region (2021-2026)

2.3.2 Global Capecitabine Revenue Forecast by Region (2021-2026)

2.4 Geographic Market Analysis: Market Facts & Figures

2.4.1 United States Capecitabine Estimates and Projections (2015-2026)

2.4.2 Europe Capecitabine Estimates and Projections (2015-2026)

2.4.3 China Capecitabine Estimates and Projections (2015-2026)

2.4.4 Japan Capecitabine Estimates and Projections (2015-2026)

2.4.5 Southeast Asia Capecitabine Estimates and Projections (2015-2026)

2.4.6 India Capecitabine Estimates and Projections (2015-2026)

3 Global Capecitabine Competition Landscape by Players

3.1 Global Top Capecitabine Players by Sales (2015-2020)

3.2 Global Top Capecitabine Players by Revenue (2015-2020)

3.3 Global Capecitabine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Capecitabine as of 2019)

3.4 Global Capecitabine Average Price by Company (2015-2020)

3.5 Manufacturers Capecitabine Manufacturing Sites, Area Served, Product Type

3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3.7 Primary Interviews with Key Capecitabine Players (Opinion Leaders)

4 Global Capecitabine Market Size by Type

4.1 Global Capecitabine Historic Market Review by Type (2015-2020)

4.1.1 Global Capecitabine Sales Market Share by Type (2015-2020)

4.1.2 Global Capecitabine Revenue Market Share by Type (2015-2020)

4.1.3 Global Capecitabine Price by Type (2014-2020)

4.2 Global Capecitabine Market Estimates and Forecasts by Type (2021-2026)

4.2.1 Global Capecitabine Sales Forecast by Type (2021-2026)

4.2.2 Global Capecitabine Revenue Forecast by Type (2021-2026)

4.2.3 Global Capecitabine Price Forecast by Type (2021-2026)

5 Global Capecitabine Market Size by Application

5.1 Global Capecitabine Historic Market Review by Application (2015-2020)

5.1.1 Global Capecitabine Sales Market Share by Application (2015-2020)

5.1.2 Global Capecitabine Revenue Market Share by Application (2015-2020)

5.1.3 Global Capecitabine Price by Application (2015-2020)

5.2 Global Capecitabine Market Estimates and Forecasts by Application (2021-2026)

5.2.1 Global Capecitabine Sales Forecast by Application (2021-2026)

5.2.2 Global Capecitabine Revenue Forecast by Application (2021-2026)

5.2.3 Global Capecitabine Price Forecast by Application (2021-2026)

3 North America Capecitabine Market Facts & Figures

3.2 North America Capecitabine Sales Market Share by Company (2015-2020)

3.3 North America Capecitabine Sales Market Share by Type (2015-2020)

3.4 North America Capecitabine Sales Market Share by Application (2015-2020)

4 Europe Capecitabine Market Facts & Figures

4.2 Europe Capecitabine Sales Market Share by Company (2015-2020)

4.3 Europe Capecitabine Sales Market Share by Type (2015-2020)

4.4 Europe Capecitabine Sales Market Share by Application (2015-2020)

5 China Capecitabine Market Facts & Figures

5.2 China Capecitabine Sales Market Share by Company (2015-2020)

5.3 China Capecitabine Sales Market Share by Type (2015-2020)

5.4 China Capecitabine Sales Market Share by Application (2015-2020)

6 Japan Capecitabine Market Facts & Figures

6.2 Japan Capecitabine Sales Market Share by Company (2015-2020)

6.3 Japan Capecitabine Sales Market Share by Type (2015-2020)

6.4 Japan Capecitabine Sales Market Share by Application (2015-2020)

7 Southeast Asia Capecitabine Market Facts & Figures

7.2 Southeast Asia Capecitabine Sales Market Share by Company (2015-2020)

7.3 Southeast Asia Capecitabine Sales Market Share by Type (2015-2020)

7.4 Southeast Asia Capecitabine Sales Market Share by Application (2015-2020)

8 India Capecitabine Market Facts & Figures

8.2 India Capecitabine Sales Market Share by Company (2015-2020)

8.3 India Capecitabine Sales Market Share by Type (2015-2020)

8.4 India Capecitabine Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Capecitabine Business

12.1 Roche

12.1.1 Roche Capecitabine Corporation Information

12.1.2 Roche Capecitabine Business Overview and Total Revenue

12.1.3 Roche Capecitabine Sales, Revenue and Gross Margin (2015-2020)

12.1.4 Roche Capecitabine Products Offered

12.1.5 Roche Recent Development

12.2 Teva

12.2.1 Teva Capecitabine Corporation Information

12.2.2 Teva Capecitabine Business Overview and Total Revenue

12.2.3 Teva Capecitabine Sales, Revenue and Gross Margin (2015-2020)

12.2.4 Teva Capecitabine Products Offered

12.2.5 Teva Recent Development

12.3 Mylan

12.3.1 Mylan Capecitabine Corporation Information

12.3.2 Mylan Capecitabine Business Overview and Total Revenue

12.3.3 Mylan Capecitabine Sales, Revenue and Gross Margin (2015-2020)

12.3.4 Mylan Capecitabine Products Offered

12.3.5 Mylan Recent Development

12.4 Hikma

12.4.1 Hikma Capecitabine Corporation Information

12.4.2 Hikma Capecitabine Business Overview and Total Revenue

12.4.3 Hikma Capecitabine Sales, Revenue and Gross Margin (2015-2020)

12.4.4 Hikma Capecitabine Products Offered

12.4.5 Hikma Recent Development

12.5 Hengrui Medicine

12.5.1 Hengrui Medicine Capecitabine Corporation Information

12.5.2 Hengrui Medicine Capecitabine Business Overview and Total Revenue

12.5.3 Hengrui Medicine Capecitabine Sales, Revenue and Gross Margin (2015-2020)

12.5.4 Hengrui Medicine Capecitabine Products Offered

12.5.5 Hengrui Medicine Recent Development

12.6 Cipla

12.6.1 Cipla Capecitabine Corporation Information

12.6.2 Cipla Capecitabine Business Overview and Total Revenue

12.6.3 Cipla Capecitabine Sales, Revenue and Gross Margin (2015-2020)

12.6.4 Cipla Capecitabine Products Offered

12.6.5 Cipla Recent Development

12.7 Reliance Group

12.7.1 Reliance Group Capecitabine Corporation Information

12.7.2 Reliance Group Capecitabine Business Overview and Total Revenue

12.7.3 Reliance Group Capecitabine Sales, Revenue and Gross Margin (2015-2020)

12.7.4 Reliance Group Capecitabine Products Offered

12.7.5 Reliance Group Recent Development

12.8 Hetero

12.8.1 Hetero Capecitabine Corporation Information

12.8.2 Hetero Capecitabine Business Overview and Total Revenue

12.8.3 Hetero Capecitabine Sales, Revenue and Gross Margin (2015-2020)

12.8.4 Hetero Capecitabine Products Offered

12.8.5 Hetero Recent Development

13 Capecitabine Manufacturing Cost Analysis

13.1 Capecitabine Key Raw Materials Analysis

13.1.1 Key Raw Materials

13.1.2 Key Raw Materials Price Trend

13.1.3 Key Suppliers of Raw Materials

13.2 Proportion of Manufacturing Cost Structure

13.3 Manufacturing Process Analysis of Capecitabine

13.4 Capecitabine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

14.1 Marketing Channel

14.2 Capecitabine Distributors List

14.3 Capecitabine Customers

15 Market Dynamics

15.1 Market Trends

15.2 Opportunities and Drivers

15.3 Challenges

15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix

17.1 Research Methodology

17.1.1 Methodology/Research Approach

17.1.2 Data Source

17.2 Author List

17.3 Disclaimer

List of Tables

Table 1. Global Capecitabine Sales (Kg) Growth Rate by Type (2020-2026)

Table 2. Global Capecitabine Sales (Kg) Comparison by Application (2020-2026)

Table 3. COVID-19 Impact Global Market: (Four Capecitabine Market Size Forecast Scenarios)

Table 4. Opportunities and Trends for Capecitabine Players in the COVID-19 Landscape

Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis

Table 6. Key Regions/Countries Measures against Covid-19 Impact

Table 7. Proposal for Capecitabine Players to Combat Covid-19 Impact

Table 8. Global Market Capecitabine Market Size (US$ Million) by Region:2015 VS 2020 &2026

Table 9. Global Capecitabine Sales (Kg) by Region (2015-2020)

Table 10. Global Capecitabine Sales Market Share by Region (2015-2020)

Table 11. Global Capecitabine Revenue (US$ Million) Market Share by Region (2015-2020))

Table 12. Global Capecitabine Revenue Share by Region (2015-2020)

Table 13. Global Capecitabine Sales (Kg) Forecast by Region (2021-2026)

Table 14. Global Capecitabine Sales Market Share Forecast by Region (2021-2026)

Table 15. Global Capecitabine Revenue (US$ Million) Forecast by Region (2021-2026)

Table 16. Global Capecitabine Revenue Share Forecast by Region (2021-2026)

Table 17. Global Capecitabine (Kg) of Key Companies (2015-2020)

Table 18. Global Capecitabine Sales Share by Company (2015-2020)

Table 19. Global Capecitabine Revenue (US$ Million) by Company (2015-2020)

Table 20. Global Capecitabine Revenue Share by Company (2015-2020)

Table 21. Global Capecitabine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Capecitabine as of 2019)

Table 22. Global Capecitabine Average Price (USD/g) of Key Company (2015-2020)

Table 23. Manufacturers Capecitabine Manufacturing Sites and Area Served

Table 24. Manufacturers Capecitabine Product Type

Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 26. Main Points Interviewed from Key Capecitabine Players

Table 27. Global Capecitabine Sales (Kg) by Type (2015-2020)

Table 28. Global Capecitabine Sales Share by Type (2015-2020)

Table 29. Global Capecitabine Revenue (US$ Million) Market Share by Type (2015-2020)

Table 30. Global Capecitabine Price (Kg) by Type (2015-2020)

Table 31. Global Capecitabine Sales Share by Type (2021-2026)

Table 32. Global Capecitabine Revenue (US$ Million) Market Share by Type (2021-2026)

Table 33. Global Capecitabine Revenue Share by Type (2021-2026)

Table 34. Global Capecitabine Price (Kg) by Type (2021-2026)

Table 35. Global Capecitabine Sales (Kg) by Application (2015-2020)

Table 36. Global Capecitabine Sales Share by Application (2015-2020)

Table 37. Global Capecitabine Revenue (US$ Million) Market Share by Application (2015-2020)

Table 38. Global Capecitabine Price (Kg) by Application (2015-2020)

Table 39. Global Capecitabine Sales (Kg) by Application (2021-2026)

Table 40. Global Capecitabine Sales Share by Application (2021-2026)

Table 41. Global Capecitabine Revenue (US$ Million) Market Share by Application (2021-2026)

Table 42. Global Capecitabine Revenue Share by Application (2021-2026)

Table 43. Global Capecitabine Price (Kg) by Application (2021-2026)

Table 44. United States Capecitabine Sales (Kg) by Company (2015-2020)

Table 45. United States Capecitabine Sales Market Share by Company (2015-2020)

Table 46. United States Capecitabine Sales (Kg) by Type (2015-2020)

Table 47. United States Capecitabine Sales Market Share by Type (2015-2020)

Table 48. United States Capecitabine Sales (Kg) by Application (2015-2020)

Table 49. United States Capecitabine Sales Market Share by Application (2015-2020)

Table 50. Europe Capecitabine Sales (Kg) by Company (2015-2020)

Table 51. Europe Capecitabine Sales Market Share by Company (2015-2020)

Table 52. Europe Capecitabine Sales (Kg) by Type (2015-2020)

Table 53. Europe Capecitabine Sales Market Share by Type (2015-2020)

Table 54. Europe Capecitabine Sales (Kg) by Application (2015-2020)

Table 55. Europe Capecitabine Sales Market Share by Type (2015-2020)

Table 56. China Capecitabine Sales (Kg) by Company (2015-2020)

Table 57. China Capecitabine Sales Market Share by Company (2015-2020)

Table 58. China Capecitabine Sales (Kg) by Type (2015-2020)

Table 59. China Capecitabine Sales Market Share by Type (2015-2020)

Table 60. China Capecitabine Sales (Kg) by Application (2015-2020)

Table 61. China Capecitabine Sales Market Share by Application (2015-2020)

Table 62. Japan Capecitabine Sales (Kg) by Company (2015-2020)

Table 63. Japan Capecitabine Sales Market Share by Company (2015-2020)

Table 64. Japan Capecitabine Sales (Kg) by Type (2015-2020)

Table 65. Japan Capecitabine Sales Market Share by Type (2015-2020)

Table 66. Japan Capecitabine Sales (Kg) by Application (2015-2020)

Table 67. Japan Capecitabine Sales Market Share by Application (2015-2020)

Table 68. Southeast Asia Capecitabine Sales (Kg) by Company (2015-2020)

Table 69. Southeast Asia Capecitabine Sales Market Share by Company (2015-2020)

Table 70. Southeast Asia Capecitabine Sales (Kg) by Type (2015-2020)

Table 71. Southeast Asia Capecitabine Sales Market Share by Type (2015-2020)

Table 72. Southeast Asia Capecitabine Sales (Kg) by Type (2015-2020)

Table 73. Southeast Asia Capecitabine Sales Market Share by Application (2015-2020)

Table 74. India Capecitabine Sales (Kg) by Company (2015-2020)

Table 75. India Capecitabine Sales Market Share by Company (2015-2020)

Table 76. India Capecitabine Sales (Kg) by Type (2015-2020)

Table 77. India Capecitabine Sales Market Share by Type (2015-2020)

Table 78. India Capecitabine Sales (Kg) by Application (2015-2020)

Table 79. India Capecitabine Sales Market Share by Application (2015-2020)

Table 80. Roche Corporation Information

Table 81. Roche Description and Business Overview

Table 82. Roche Capecitabine Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)

Table 83. Roche Capecitabine Product

Table 84. Roche Recent Development

Table 85. Teva Corporation Information

Table 86. Teva Description and Business Overview

Table 87. Teva Capecitabine Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)

Table 88. Teva Capecitabine Product

Table 89. Teva Recent Development

Table 90. Mylan Corporation Information

Table 91. Mylan Description and Business Overview

Table 92. Mylan Capecitabine Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)

Table 93. Mylan Capecitabine Product

Table 94. Mylan Recent Development

Table 95. Hikma Corporation Information

Table 96. Hikma Description and Business Overview

Table 97. Hikma Capecitabine Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)

Table 98. Hikma Capecitabine Product

Table 99. Hikma Recent Development

Table 100. Hengrui Medicine Corporation Information

Table 101. Hengrui Medicine Description and Business Overview

Table 102. Hengrui Medicine Capecitabine Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)

Table 103. Hengrui Medicine Capecitabine Product

Table 104. Hengrui Medicine Recent Development

Table 105. Cipla Corporation Information

Table 106. Cipla Description and Business Overview

Table 107. Cipla Capecitabine Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)

Table 108. Cipla Capecitabine Product

Table 109. Cipla Recent Development

Table 110. Reliance Group Corporation Information

Table 111. Reliance Group Description and Business Overview

Table 112. Reliance Group Capecitabine Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)

Table 113. Reliance Group Capecitabine Product

Table 114. Reliance Group Recent Development

Table . Hetero Corporation Information

Table . Hetero Capecitabine Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)

Table . Hetero Description and Business Overview

Table . Hetero Capecitabine Product

Table . Hetero Recent Development

Table 120. Production Base and Market Concentration Rate of Raw Material

Table 121. Key Suppliers of Raw Materials

Table 122. Capecitabine Distributors List

Table 123. Capecitabine Customers List

Table 124. Market Key Trends

Table 125. Key Opportunities and Drivers: Impact Analysis (2020-2026)

Table 126. Key Challenges

Table 127. Research Programs/Design for This Report

Table 128. Key Data Information from Secondary Sources

Table 129. Key Data Information from Primary Sources

List of Figures

Figure 1. Capecitabine Product Picture

Figure 2. Global Capecitabine Sales Market Share by Type in 2020 & 2026

Figure 3. Type I Product Picture

Figure 4. Type II Product Picture

Figure 5. Global Capecitabine Market Share by Application in 2020 & 2026

Figure 6. Breast Cancer Examples

Figure 7. Colorectal Cancer Examples

Figure 8. Stomach Cancer Examples

Figure 9. Global Capecitabine Sales (Kg) Growth Rate (2015-2026)

Figure 10. Global Capecitabine Revenue (US$ Million) Growth Rate (2015-2026)

Figure 11. Global Capecitabine Price Trends Growth Rate (2015-2026) (USD/g)

Figure 12. Global Capecitabine Revenue Market Share by Region: 2015 VS 2020

Figure 13. Global Capecitabine Revenue Market Share by Region: 2021 VS 2026

Figure 14. United States Capecitabine Revenue (Million USD) Growth Rate (2015-2026)

Figure 15. United States Capecitabine Sales (Kg) Growth Rate (2015-2026)

Figure 16. Europe Capecitabine Revenue (Million USD) Growth Rate (2015-2026)

Figure 17. Europe Capecitabine Sales (Million USD) Growth Rate (2015-2026)

Figure 18. China Capecitabine Revenue (Million USD) Growth Rate (2015-2026)

Figure 19. China Capecitabine Sales (Million USD) and Growth Rate (2015-2026)

Figure 20. Japan Capecitabine Revenue (Million USD) Growth Rate (2015-2026)

Figure 21. Japan Capecitabine Sales (Million USD) Growth Rate (2015-2026)

Figure 22. Southeast Asia Capecitabine Revenue (Million USD) Growth Rate (2015-2026)

Figure 23. Southeast Asia Capecitabine Sales (Million USD) Growth Rate (2015-2026)

Figure 24. India Capecitabine Revenue (Million USD) Growth Rate (2015-2026)

Figure 25. India Capecitabine Sales (Million USD) Growth Rate (2015-2026)

Figure 26. Global 5 Largest Capecitabine Players Market Share by Revenue in Capecitabine 2015 & 2019

Figure 27. Capecitabine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 28. Global Capecitabine Revenue Share by Type (2015-2020)

Figure 29. Global Capecitabine Revenue Growth Rate by Type in 2015 & 2019

Figure 30. Global Capecitabine Revenue Share by Application (2015-2020)

Figure 31. Global Capecitabine Revenue Growth Rate by Application in 2015 & 2019

Figure 32. United States Capecitabine Sales Market Share by Type in 2019

Figure 33. United States Capecitabine Sales Market Share by Type in 2019

Figure 34. Europe Capecitabine Sales Market Share by Company in 2019

Figure 35. Europe Capecitabine Sales Market Share by Type in 2019

Figure 36. Europe Capecitabine Sales Market Share by Application in 2019

Figure 37. China Capecitabine Sales Market Share by Company in 2019

Figure 38. China Capecitabine Sales Market Share by Type in 2019

Figure 39. China Capecitabine Sales Market Share by Application in 2019

Figure 40. Japan Capecitabine Sales Market Share by Company in 2019

Figure 41. Japan Capecitabine Sales Market Share by Type in 2019

Figure 42. Japan Capecitabine Sales Market Share by Application in 2019

Figure 43. Southeast Asia Capecitabine Sales Market Share by Company in 2019

Figure 44. Southeast Asia Capecitabine Sales Market Share by Type in 2019

Figure 45. Southeast Asia Capecitabine Sales Market Share by Application in 2019

Figure 46. India Capecitabine Sales Market Share by Company in 2019

Figure 47. India Capecitabine Sales Market Share by Type in 2019

Figure 48. India Capecitabine Sales Market Share by Application in 2019

Figure 49. Roche Total Revenue (US$ Million): 2019 Compared with 2018

Figure 50. Teva Total Revenue (US$ Million): 2019 Compared with 2018

Figure 51. Mylan Total Revenue (US$ Million): 2019 Compared with 2018

Figure 52. Hikma Total Revenue (US$ Million): 2019 Compared with 2018

Figure 53. Hengrui Medicine Total Revenue (US$ Million): 2019 Compared with 2018

Figure 54. Cipla Total Revenue (US$ Million): 2019 Compared with 2018

Figure 55. Reliance Group Total Revenue (US$ Million): 2019 Compared with 2018

Figure 56. Hetero Total Revenue (US$ Million): 2019 Compared with 2018

Figure 57. Key Raw Materials Price Trend

Figure 58. Manufacturing Cost Structure of Capecitabine

Figure 59. Manufacturing Process Analysis of Capecitabine

Figure 60. Capecitabine Industrial Chain Analysis

Figure 61. Channels of Distribution

Figure 62. Distributors Profiles

Figure 63. Porter's Five Forces Analysis

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

---